Patent Assignment
Reel/Frame 047099/0366
Security Interest
Recorded: 2018-10-09
Pages: 7
Assignor
AGALIMMUNE LTD.
Executed: 2018-10-08
Assignee
KREOS CAPITAL V (EXPERT FUND) L.P.
47 ESPLANADE, ST HELIER, JERSEY
Covered Properties
(4)
Tumor Lesion Regression and Conversion in Situ into Autologous Tumor Vaccines by Compositions That Result in Anti-Gal Antibody Binding
Glycolipid Containing Compositions for Use in the Treatment of Tumors
Therapeutic Compositions and Methods of Use for Treating Cancer
Application:
15/564,774 →
Publication:
US 2018/0104288
Glycolipid Compounds and Their Uses in the Treatment of Tumours
Application:
15/771,692 →
Publication:
US 2018/0344805
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 20, 2006
From: GALILI, URI
To: UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
Reel/Frame 018118/0315 →
Assignment of Assignor's Interest
Jan 4, 2017
From: GALILI, URI; PICKFORD, CHRISTOPHER; GRIFFITHS, GRAHAM JOHN CHARLES
To: AGALIMMUNE LIMITED
Reel/Frame 041244/0221 →
Assignment of Assignor's Interest
May 18, 2018
From: GRIFFITHS, GRAHAM; SHAW, STEPHEN
To: AGALIMMUNE LIMITED
Reel/Frame 045840/0340 →
Assignment of Assignor's Interest
May 18, 2018
From: BOVIN, NICOLAI VLADIMIROVICH; TUZIKOV, ALEXANDER BORISOVICH; KORCHAGINA, ELENA YURIEVNA; HENRY, STEPHEN
To: KODE BIOTECH LIMITED
Reel/Frame 045840/0383 →
Assignment of Assignor's Interest
May 18, 2018
From: GALILI, URI; SHAW, STEPHEN; WESTBY, MICHAEL
To: AGALIMMUNE LIMITED
Reel/Frame 045841/0172 →
Security Interest
Oct 27, 2020
From: BIOLINE RX LTD.
To: KREOS CAPITAL V (EXPERT FUND) L.P.
Reel/Frame 054172/0318 →